These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13807360)

  • 1. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N; MAFFEI-FACCIOLI A
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 4. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H; ERICKSON RW
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():407-25. PubMed ID: 13901404
    [No Abstract]   [Full Text] [Related]  

  • 5. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature.
    DUBNICK B; LEESON GA; CHESSIN M; SCOTT CC
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():194-202. PubMed ID: 13818306
    [No Abstract]   [Full Text] [Related]  

  • 6. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
    WEIL-MALHERBE H; POSNER HS; BOWLES GR
    J Pharmacol Exp Ther; 1961 Jun; 132():278-86. PubMed ID: 13783846
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 14. NEW ORALLY ACTIVE MONOAMINE OXIDASE (MAO) INHIBITORS.
    JORI A; BONACCORSI A; VALZELLI L; GARATTINI S
    Life Sci (1962); 1963 Aug; 8():611-7. PubMed ID: 14058510
    [No Abstract]   [Full Text] [Related]  

  • 15. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
    ZBINDEN G
    Am J Cardiol; 1960 Dec; 6():1121-4. PubMed ID: 13788034
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase inhibition and the induction of ponto-geniculo-occipital wave activity by reserpine in the cat.
    Gershon MD; Brooks DC
    J Pharmacol Exp Ther; 1976 Jun; 197(3):556-66. PubMed ID: 6784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempted correlations between behavioural and biochemical changes in rats following reserpine and chronic administration of amine-oxidase inhibitors.
    ACHESON RM; COLE J; DEARNALEY DP; DEARNALEY EJ
    Psychopharmacologia; 1961; 2():277-94. PubMed ID: 13681211
    [No Abstract]   [Full Text] [Related]  

  • 19. MECHANISM OF ACTION OF RESERPINE AND INSULIN ON GASTRIC AMINES AND GASTRIC ACID SECRETION, AND THE EFFECT OF MONOAMINE OXIDASE INHIBITION.
    KIM KS; SHORE PA
    J Pharmacol Exp Ther; 1963 Sep; 141():321-5. PubMed ID: 14064194
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between pyrexia and amine levels in brain with special reference to the action of monoamine oxidase inhibitor].
    TAKASHIMA H
    Nihon Yakurigaku Zasshi; 1962 Sep; 58():437-48. PubMed ID: 13984593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.